IGC Pharma, Inc. - COM NEW (IGC)

CUSIP: 45408X308

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / COM NEW
Total 13F shares
3,256,530
Share change
+1,154,835
Total reported value
$5,077,000
Put/Call ratio
151%
Price per share
$1.56
Number of holders
20
Value change
+$1,886,338
Number of buys
11
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 45408X308?
CUSIP 45408X308 identifies IGC - IGC Pharma, Inc. - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q4 2020

As of 31 Dec 2020, IGC Pharma, Inc. - COM NEW (IGC) was held by 20 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,256,530 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, Carroll Financial Associates, Inc., SUSQUEHANNA INTERNATIONAL GROUP, LLP, GEODE CAPITAL MANAGEMENT, LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, DEARBORN PARTNERS LLC, GOLDMAN SACHS GROUP INC, NORTHERN TRUST CORP, and TRUIST FINANCIAL CORP. This page lists 20 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.